AK 1 catalyzes the reversible reaction ATP+AMP  2ADP thus contributing to the regulation of relative concentration of these important nucleotides. Intracellular ATP is a storage of energy for cellular processes, moreover extracellular ATP together with ADP, AMP and adenosine are critical signalling molecule for sending messages to nearby cells acting on P1 and P2 receptors. AK 1 shows a genetic polymorphism and recently our group has shown that the correlation between blood glucose and glycated haemoglobin in T2D is dependent on AK 1 phenotype. In the present paper we have carried further studies on the relationship between AK 1 phenotypes and T2D. Possible interactions with ABO blood groups and ACP1 polymorphism have also been investigated. We have re-examined the data on 280 subjects with type 2 diabetes from the White population of Penne (Central Italy). 384 consecutive healthy newborns from the same population have been also studied. A three way contingency table analysis was carried out according to Sokal and Rohlf and other statistical analyses by SPSS programs. T2D patients with AK 1 2-1 phenotype have higher values of blood glucose level and glycated haemoglobin and an increased tendency to dyslipidemia and retinopathy. In addition there is an interaction of AK 1 with ABO blood groups and with ACP 1 polymorphism. The different activity between AK 1 phenotypes could influence the relative concentration of ATP, ADP, AMP and adenosine with important effects on metabolic activity thus explaining the association of AK 1 with clinical manifestation of T2D.
INTRODUCTION
Adenylate kinase (AK) is an ubiquitous enzyme that catalyzes the nucleotide phosphoryl interconversion ATP + AMP  2ADP. The products of this reaction are involved in the regulation of many cellular function and relationship. Intracellular ATP is a storage of energy for cellular processes. The energy from extracellular ATP is used for sending messages to nearby cells.
At first, extracellular ATP was seen simply as a neurotransmitter, subsequently was studied the mechanism of interactions between extracellular ATP signalling with other signalling systems outside the cells named ectoATPases. This large family of AK enzyme removes from ATP, one by one, its phosphates producing adenosine diphosphate (ADP), adenosine monophosphate (AMP) and adenosine that have different effect on several cells by binding themselfes to P2 family (for ADP, AMP) and to P1 (for adenosine) receptors 1].
The family of AK enzymes includes seven genes, AK 1 -AK 7 , with each other different functions,molecular weight and kinetic property. The network of these enzymes are distributed throughout intracellular compartments, interstitial space and body fluids to regulate energetic and metabolic signaling circuits and to fasten an efficient economy of cell energy, signal communication and stress response.Mutations in AK 1 , AK 2 or AK 7 genes have been found associated with hemolytic anemia, reticular dysgenesis and ciliary dyskinesia 2].
Adenylate kinase locus 1 (AK 1 ) belongs to AK family and plays an important role in the synthesis of nucleotides requested for many metabolic functions. It is present in the cytosol of skeletal muscle, brain, and erythrocyte. The enzyme is polymorphic and shows three phenotypes with different activity, in the order AK 1 1 > AK 1 2-1 > AK 1 2 corresponding to the presence of two codominant alleles, AK 1 *1 and AK 1 *2 at an autosomal locus on chromosome 9. Rare alleles AK 1 *3, AK 1 *4 and AK 1 *5 have been also referred.
AK 1 was identified because of its association with a rare genetic disorder causing nonspherocytic hemolytic anemia where a mutation in the AK 1 gene was found to reduce the catalytic activity of the enzyme and the replacement of Arg-128 with Trp 3].
Our group has recently shown that the correlation between blood glucose and glycated haemoglobin in T2D is dependent on AK 1 phenotype. In addition, blood glucose is significantly higher in AK 1 2-1 than in AK 1 
MATERIAL AND METHODS
We have re-examined the data on 278 subjects with type 2 diabetes from the population of Penne (Italy) and have studied 384 consecutive healthy newborns from the same population. T2D patients have been considered in a previous study 6] and were a random sample of a population of about 2000 subjects under care at Centre of Diabetology of the local Hospital. Penne is a rural town located in Eastern side of Central Italy. This homogenous population are the descendant of an old Italic population called "Vestini". The total number of subjects shown in the tables are not always the same due to some random missing value for the variables considered.
The patients have been controlled in the Centre of Diabetology according to a regular schedule. In occasion of the control blood glucose and glycated haemoglobin levels have been measured (more than 9 hours since the last meal). Blood sample for determination of genetic markers were also obtained. Written informed consent was obtained from patients and from mothers of newborns to participate to this study that was approved by the Institutional Review Board.
Laboratory Analysis
Serum glucose concentration was measured by the automated Roche/Hitachi cobas C501 system based on enzymatic reaction with exochinase. Glycated haemoglobin was determined using the Menarini Diagnostics HA-8160 automated equipment based on inverse exchange cationic chromatography.
AK 1 phenotype was determined by starch gel electrophoresis of haemolysate 7]. Samples were examined at pH7. The insert were made from Whatman, n˚3 filter paper. After electrophoresis the gels were sliced and then covered with a 0.75% agar solution at 45˚C made in 0.1 M tris buffer pH 8 and containing glucose 10 mM, magnesium chloride 20 mM, adenosine diphosphate (ADP) 1 mM, nicotinammide adenine dinucleotide phosphate (NA-DP) 0.4 mM, phenazine methosulphate (PMS) 0.012%, tetrazolium salt (MTT) 0.012%, glucose-6-phosphate dehydrogenase (G6PD) 0.04 units/ml and hexokinase 0.08 units/ml. The agar was allowed to set and then the gel incubated at 37˚C for two hours.
At the sites of AK activity ADP is converted into AMP and ATP. The ATP reacts with glucose in the presence of hexokinase to produce ADP and glucose-6-phosphate (G6P), this is oxidized to 6-phosphogluconate by G6PD with concomitant reduction of NADP. The reduced NADP in the presence of PMS causes the reduction of MTT to give a blue-coloured insoluble formazan, which is thus deposited at the sites of AK activity. In Caucasian populations three distinct types of electrophoretic pattern are recognized referred as AK 1 The addendum of ammonium solution reveals the area where phenophtalein has been liberated in the areas of gel where ACP 1 activity is present. In European populations, the presence of three common alleles *A, *B and *C determines the occurrence of six phenotypes with enzymatic activity increasing in the order: A < AB < B< AC < BC < C. Each of the homozygous A, B, and C phenotypes are composed of two fractions F and S corresponding to a fast and slow component of electrophoretic pattern. Heterozygous phenotypes have a pattern corresponding to a mixture of homozygous types. 
Statistical Analysis

RESULTS
Clinical and demographic data in subjects with T2D and in healthy newborns are shown in Table 1 .
In T2D the frequency of AK 1 2-1 is slightly greater in comparison to healthy newborns but the difference is not statistically significant (see Table 2 ). The data suggest that Ak 1 may not be an important factor primarily involved in the susceptibility to type 2 diabetes.
The distributions of blood glucose and glycated Hb are shown in Table 3 . Both parameters show a greater value in AK 1 2-1 than in AK 1 1 but only for blood glucose Openly accessible at http://www.scirp.org/journal/HEALTH/ the difference is statistically significant. The proportion of subjects with dyslipidemia and retinopathy is greater in AK 1 2-1 than in AK 1 1 but the difference does not reach the level of statistical significance (see Table 4 ).
In T2D the proportion of AK2-1 phenotype is very high in B blood group and very low in A group. The difference between A and B blood groups is highly significant (O.R. = 10.173 C.I. 2.151-39.163). No significant association has been observed between ABO and AK 1 phenotypes in healthy newborns (see Table 5 ). Table 6 shows in T2D subjects the distribution of blood glucose and glycated Hb in relation to the joint ABO-AK 1 phenotypes. Both parameters in A and O subjects show higher values in those carrying the AK 1 2-1 phenotype than in those carrying the AK 1 1 phenotype while in B subjects there is a slight tendency to a reduction of both parameters in AK 1 2-1phenotype as compared to Ak1 phenotype. Figure 1 displays the relationship between serum glucose level and ACP1 enzymatic activity in AK 1 1 and AK 1 2-1 subjects with T2D. In AK 1 1 phenotype the concentration of serum glucose is positively correlated with ACP1 activity while in AK 1 2-1 phenotype the association follows an opposite pattern.
DISCUSSION
The present data show that T2D patients with AK 1 2-1 phenotype have higher values of blood glucose level and glycated haemoglobin and have an increased tendency to dyslipidemia and retinopathy. In addition there is an interaction of AK 1 with ABO blood groups and ACP 1 polymorphism.
AK 1 belongs to AK family and, at the sites of AK 1 activity, ADP is converted into AMP and ATP. The reaction is reversible thus contributing to the regulation of relative concentration of these important nucleotides 1]. Extracellular ATP plays a physiological role in the maintenance of glucose homeostasis by regulating insulin secretion 11]. ATP is able to stimulate the release of pancreatic insulin modulating glucose transport via GLUT1 acting on P2 purinergic ionotropic (P2X) and P2 metabotropic (P2Y) receptors through a mechanism that involves beta-cell metabolism and a rise of intracellular calcium. P2Y receptors are deficient in fibroblasts from T2D patients 12]. The differences in enzymatic activity between AK 1 phenotypes could influence the relative concentration of ATP, ADP, AMP and adenosine influencing metabolic parameters and contributing to explain the association with clinical manifestation in T2D. Further investigation in this area could be rewarding. Our research is in line with the recent interest on genetic variants that through the regulation of insulin secretion by -cells could be involved in the pathogenesis and clinical manifestations of type 2 diabetes. 17].
Genetic variability of ABO blood groups substances that are important components of cell membrane structure may influence AK 1 ecto-enzyme activity thus explaining the associations reported in Tables 5 and 6 .
In general high activity of ACP 1 is associated with high blood glucose level. Low AK 1 activity modifying the ratio among ATP, ADP and AMP may influence the effect of ACP 1 activity on blood glucose resulting in lower glucose level in carriers of high ACP 1 activity genotypes.
CONCLUSION
Low adenylate kinase activity associated to AK 1 2-1 phenotype influencing the relative concentration of ATP, 
